ReviewJournal of anesthesia and translational medicine2025
What is new in cardiac anesthesia in 2024?
Review in Journal of anesthesia and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The significance of S100β and neuron-specific enolase (NSE) in postoperative cognitive dysfunction following cardiac surgery: a systematic review and meta-analysis.European journal of medical research · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in cardiac anesthesia have led to improved patient care and safety. In 2024, there is a growing focus on patient-centered approaches aimed at improving overall outcomes. This includes the adoption of Enhanced Recovery After Surgery (ERAS) protocols to promote faster recovery and enhance patient satisfaction, multimodal pain management strategies to minimize opioid use while improving patient comfort, and conservative blood transfusion practices to mitigate risk and enhance the quality of patient care. The expansion of anesthesia practice beyond traditional operating rooms offers greater flexibility and efficacy in managing patients during diagnostic and therapeutic interventions. Technological innovations are also transforming the field. The role of pulmonary artery catheterization in perioperative cardiopulmonary function monitoring and management for high-risk patients remains a subject of debate. Concurrently, continuous assessment of cardiac and pulmonary function, coupled with the development of clinically relevant cardiac biomarkers, more specific medications, and enhanced monitoring devices, contributes to better management and perioperative outcomes. Furthermore, machine learning (ML) algorithms, artificial intelligence (AI) and virtual reality (VR) are playing an increasingly crucial role in training and improving clinical decision-making in complex cases. These innovations have the potential to further revolutionize cardiac anesthesia in the coming years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.